Mean Platelet Volume in Crohn’s Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study

BACKGROUND: The loss of response to infliximab in Crohn’s disease (CD) patients is currently a major clinical problem. Recently, mean platelet volume (MPV) has been proposed as a new biomarker of CD activity. Here, we hypothesized that MPV may be used as cheap and efficient biomarker of subclinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobolewska, Aleksandra, Włodarczyk, Marcin, Stec-Michalska, Krystyna, Fichna, Jakub, Wiśniewska-Jarosińska, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729800/
https://www.ncbi.nlm.nih.gov/pubmed/26441277
http://dx.doi.org/10.1007/s10620-015-3894-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729800/
https://www.ncbi.nlm.nih.gov/pubmed/26441277
http://dx.doi.org/10.1007/s10620-015-3894-3

Ejemplares similares